Healthcare provider profile · identity verified

Sujay Banerjee, MD

Family Practice · WALNUT CREEK, CA · NPI 1174601249

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	875	308
Amlodipine Besylate	Amlodipine Besylate	496	187
Lisinopril	Lisinopril	280	101
Levothyroxine Sodium	Levothyroxine Sodium	277	87
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	259	49
Tamsulosin Hcl	Tamsulosin Hcl	248	89
Losartan Potassium	Losartan Potassium	219	74
Atenolol	Atenolol	205	72
Albuterol Sulfate Hfa	Albuterol Sulfate	170	87
Hydrochlorothiazide	Hydrochlorothiazide	155	62
Metformin Hcl Er	Metformin Hcl	154	55
Simvastatin	Simvastatin	149	52
Allopurinol	Allopurinol	145	49
Metoprolol Tartrate	Metoprolol Tartrate	143	51
Pantoprazole Sodium	Pantoprazole Sodium	141	53
Ozempic	Semaglutide	135	22
Fluticasone Propionate	Fluticasone Propionate	130	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	128	50
Gabapentin	Gabapentin	127	57
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	118	17
Trazodone Hcl	Trazodone Hcl	117	40
Alendronate Sodium	Alendronate Sodium	109	38
Metformin Hcl	Metformin Hcl	105	39
Finasteride	Finasteride	100	36
Azelastine Hcl	Azelastine Hcl	98	35
Alvesco	Ciclesonide	89	38
Furosemide	Furosemide	86	40
Pradaxa	Dabigatran Etexilate Mesylate	81	27
Rosuvastatin Calcium	Rosuvastatin Calcium	79	30
Omeprazole	Omeprazole	78	36
Spironolactone	Spironolactone	78	28
Famotidine	Famotidine	73	32
Hydralazine Hcl	Hydralazine Hcl	72	33
Glipizide	Glipizide	70	25
Lorazepam	Lorazepam	64	27
Ibuprofen	Ibuprofen	63	27
Metoprolol Succinate	Metoprolol Succinate	57	24
Doxycycline Monohydrate	Doxycycline Monohydrate	55	36
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	20
Terazosin Hcl	Terazosin Hcl	55	20
Triamcinolone Acetonide	Triamcinolone Acetonide	51	26
Glipizide Er	Glipizide	49	22
Amoxicillin	Amoxicillin	45	29
Wixela Inhub	Fluticasone Propion/Salmeterol	45	22
Prednisone	Prednisone	44	34
Fluoxetine Hcl	Fluoxetine Hcl	43	16
Spiriva Respimat	Tiotropium Bromide	43	13
Carvedilol	Carvedilol	42	18
Shingrix	Varicella-Zoster Ge/As01b/Pf	42	34
Acetaminophen-Codeine	Acetaminophen With Codeine	41	suppressed
Lovastatin	Lovastatin	41	16
Temazepam	Temazepam	40	11
Fluconazole	Fluconazole	39	17
Morphine Sulfate Er	Morphine Sulfate	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	39	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	16
Tizanidine Hcl	Tizanidine Hcl	36	23
Citalopram Hbr	Citalopram Hydrobromide	35	11
Ondansetron Hcl	Ondansetron Hcl	34	15
Sertraline Hcl	Sertraline Hcl	33	15
Colchicine	Colchicine	31	16
Arexvy	Rsvpref3 Antigen/As01e/Pf	29	29
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	29	29
Meloxicam	Meloxicam	29	16
Montelukast Sodium	Montelukast Sodium	29	12
Duloxetine Hcl	Duloxetine Hcl	28	12
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	18
Oxybutynin Chloride Er	Oxybutynin Chloride	27	11
Potassium Chloride	Potassium Chloride	27	14
Jardiance	Empagliflozin	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	11
Lactulose	Lactulose	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Cephalexin	Cephalexin	24	19
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	11
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Baclofen	Baclofen	23	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	12
Clonazepam	Clonazepam	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Acyclovir	Acyclovir	21	11
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Promethazine Hcl	Promethazine Hcl	21	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Azithromycin	Azithromycin	20	16
Bupropion Xl	Bupropion Hcl	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	16
Fluocinonide	Fluocinonide	20	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	13
Naproxen	Naproxen	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	18	18
Fenofibrate	Fenofibrate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Hydrocortisone	Hydrocortisone	17	11
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Humulin N	Insulin Nph Human Isophane	15	suppressed
Metronidazole	Metronidazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Probenecid	Probenecid	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Nystatin	Nystatin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Primidone	Primidone	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Valganciclovir Hcl	Valganciclovir Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error